Barometer Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Barometer Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Buy	5,370 +1,200	+29%	+$280K	0.4%	56
2026 Q1	$954K	Sell	4,170 -87,222	-95%	-$19.6M	0.33%	72
2025 Q4	$10.8M	Buy	91,392 +87,488	+2,241%	+$18.1M	2.61%	18
2025 Q3	$776K	Buy	3,904 +2,900	+289%	+$541K	0.18%	81
2025 Q2	$173K	Hold	1,004	–	–	0.05%	154
2025 Q1	$156K	Buy	+1,004	New	+$143K	0.06%	125
2024 Q4	–	Sell	-1,004	Closed	-$150K	–	140
2024 Q3	$150K	Hold	1,004	–	–	0.04%	137
2024 Q2	$137K	Sell	1,004 -2,100	-68%	-$286K	0.05%	153
2024 Q1	$430K	Buy	3,104 +2,104	+210%	+$300K	0.11%	98
2023 Q4	$126K	Buy	+1,000	New	+$99.7K	0.04%	115

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Barometer Capital Management's ASND Position: Q2 2026 in Review

Barometer Capital Management increased its Ascendis Pharma A/S (ASND) stake by 29% in Q2 2026, buying an estimated $280K and bringing the position to 5,370 shares worth $1.43M. The position accounts for 0.4% of the portfolio, ranked #56.

Barometer Capital Management first reported a position in ASND in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.8M in Q4 2025. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Barometer Capital Management held 5,370 shares of Ascendis Pharma A/S worth $1.43M as of Q2 2026.
Barometer Capital Management bought 1,200 Ascendis Pharma A/S shares in Q2 2026, an estimated $280K.
Ascendis Pharma A/S made up 0.4% of Barometer Capital Management's portfolio in Q2 2026, its #56 holding.
Barometer Capital Management first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 10 quarters since.
Barometer Capital Management's Ascendis Pharma A/S position peaked at $10.8M in Q4 2025.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Barometer Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.